Ontology highlight
ABSTRACT:
SUBMITTER: Davila ML
PROVIDER: S-EPMC3615434 | biostudies-literature | 2013 Apr
REPOSITORIES: biostudies-literature
Davila Marco L ML Brentjens Renier R
Hematology/oncology clinics of North America 20130401 2
Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL. Because adoptive transfer of CAR-modified T cells is a novel approach, there are issues for the medical oncologist to consider when evaluating current and future clinical trials for CLL patients. This article reviews the impact of CA ...[more]